Tirzepatide Most scientifically supported peptide for weight loss Pros Dual-agonist action for improved efficacy Has led to greater weight loss in clinical studies compared to semaglutide Usually only a once-a-week administration Cons Potentially higher side effect risk than semaglutide Less available online than semaglutide Tirzepatide is a dual agonist, which means it simulates the activities of not one but two hormones: GLP-1: stimulates insulin secretion, inhibits glucagon secretion, slows digestion, and increases feelings of fullness7 GIP: stimulates insulin secretion and helps to reduce fat accumulation14 Thanks to tirzepatides two-part action against obesity factors, it has risen to the top of the hierarchy among all therapeutic peptides currently used for weight loss
Choose carbs that nourish rather than inflame: Sweet potatoes Quinoa Oats (steel-cut or rolled) Brown or wild rice Squash These provide steady energy without spiking glucose or insulin
This increases the risk of contamination , improper dosing, and adverse reactions due to inconsistent product quality
Furthermore, increased TMAO levels have been identified as an independent predictor of poor prognosis in patients with diabetic cardiomyopathy (Figure 1)
Regular exercise and a healthy diet are usually recommended for weight loss
Anesthesia Considerations for a research subjects on Semaglutide and Delayed Gastric [PMID: 37602101] Laboratory literature summary: Anesthesia Considerations for a research subjects on Semaglutide and Delayed Gastric Emptying